Clinical trials
Preterm Infant clinical trials
Below are recruiting preterm infant clinical trials, each written for real people, not researchers. We’re tracking 156 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07030270Recruiting
Comparing surfactant delivery methods for preterm infants
This trial compares two ways to give surfactant (a substance that helps preterm babies' lungs work better) to preterm infants who need breathing support. It studies whether a small tube placed through the throat or a thin catheter works better for delivering the medication.
Dallas, TexasAges birth–3 days - NCT06940856Recruiting
Chloride imbalance in preterm babies
This study looks at chloride levels in preterm babies admitted to the neonatal intensive care unit (NICU) within their first day of life. It aims to understand chloride imbalance and how it might affect their health.
Istanbul, TurkeyAges 1 hour–1 month - NCT06648083Recruiting
How very premature babies learn to eat by mouth
This study looks at how very premature babies (born at 28 weeks or earlier) learn to eat by mouth and whether they develop any feeding or mouth problems later. Researchers will review medical records from past years to see what helped or hindered their progress.
LyonAges Up to 6 months - NCT05589831Recruiting
Test breathing support and brain health in premature babies
This study checks how a type of breathing machine support affects brain health in very premature infants. It may help doctors choose safer breathing support strategies to protect the brain.
Toronto, OntarioAges 3 days+ - NCT05617833RecruitingPhase 1
Test EPO and melatonin for brain bleeding in very preterm babies
This Phase 1 trial studies whether giving erythropoietin (EPO) and melatonin is safe in very preterm infants who have bleeding in the brain (intraventricular hemorrhage) or significant nearby brain injury. It aims to see if these medicines can be given safely during the early days after birth.
St. Petersburg, FloridaAges 12 hours–2 months - NCT07247474Recruiting
Using electrical impedance tomography for heart and lung imaging
This trial uses a safe, non-invasive technique called EIT to monitor heart and lung function in children and young adults with certain heart or lung conditions, compared with healthy volunteers. It may help doctors better understand and manage these conditions.
Aurora, ColoradoAges 2 weeks–25 years - NCT07660965Recruiting
Podcast breastfeeding training for mothers of preterm infants
This trial tests whether listening to a podcast about breastfeeding helps mothers of preterm babies feel more confident and successful at breastfeeding. If you are a Turkish-speaking mother of a baby born between 32 and 37 weeks, you may be eligible.
Merkez, OrduAges 18 years+ - NCT07219784Enrolling by invitation
Abdominal binders for feeding in preterm babies on breathing support
This study tests whether a soft abdominal binder (a wrap around the belly) helps preterm babies on breathing support keep their milk feeds going without interruptions. It might help reduce pauses in feeding and support growth.
Albany, New YorkAges Up to 1 year - NCT07561125RecruitingPhase 2
IVIG for lung disease in very preterm infants
This trial tests whether giving intravenous immunoglobulin (IVIG) early after birth can help prevent or treat a serious lung condition called bronchopulmonary dysplasia (BPD) in babies born at 28 weeks or earlier. It may help reduce the need for breathing support and oxygen.
ShanghaiAges 1 day–2 months - NCT04064177Recruiting
Noninvasive heart monitoring for newborns
This study tests a noninvasive way to continuously measure heart output (how well the heart is pumping) in newborn babies. It may help clinicians monitor babies more safely and adjust care sooner.
LondonAges 1 hour–9 months - NCT04114435Recruiting
Heart and lung testing in extremely premature babies
This study looks at how the hearts and lungs work in babies born very early (before 29 weeks). It may help researchers understand why some babies develop breathing and heart circulation problems and how to measure their recovery.
Montreal, QuebecAges 1 week–5 years - NCT04430790RecruitingPhase 3
Doxapram for apnea in very preterm babies on breathing support
This trial studies whether the medicine doxapram can better treat breathing pauses (apnea) in very preterm babies who are already on breathing support in the NICU. It aims to reduce the need for extra interventions and improve outcomes in this high-risk group.
Brussels, Avenaue Hippocrate 10Ages 5 months–7 months - NCT04911452Recruiting
Calmer NICU care for very preterm babies
This study tests a calmer approach in the NICU to help very preterm babies grow and develop their brains. It may be helpful if your baby needs breathing support and is in the early weeks of life.
Vancouver, British ColumbiaAges 6 months–7 months - NCT05017389Recruiting
Long-term health follow-up for premature newborns
This study follows babies born early (premature) over the long term to learn how they grow and develop. It mainly helps doctors understand long-term health needs after early birth.
Shanghai, Shanghai MunicipalityAges 2 weeks–4 months - NCT05063149RecruitingPhase 3
Preemie immune treatment to prevent lung infections and wheezing
This study tests whether a bacterial “lysate” medicine, given to preterm babies, can reduce respiratory (lung) infections and wheezing. It may help protect babies’ airways during the vulnerable first months after birth.
Rotterdam, South HollandAges 1 month–2 months - NCT05223192Recruiting
Testing music to improve breathing and brain oxygen in preemies
This study looks at whether planned music sessions can help preterm babies breathe more steadily and improve oxygen reaching the brain. It may help staff learn how to use music therapy safely for newborns in the NICU.
New York, New YorkAges 6 months–9 months - NCT05231200Recruiting
Improving care for late preterm babies in NICUs
This trial uses a “quality improvement” program to improve how late preterm babies are cared for in participating hospitals’ newborn units. It may help families indirectly by improving team practices and coordination in the NICU.
Calgary, AlbertaAges 7 months–8 months - NCT05272579RecruitingEarly Phase 1
Phage treatment to help gut development in very preterm babies
This early-phase trial tests whether giving a specific bacteria-fighting treatment (called bacteriophage) through the gut can help preterm babies’ intestinal development mature faster. It may help reduce early gut-related problems, but the study is mainly to check safety and early effects.
CopenhagenAges Any age - NCT05285345Recruiting
A new discharge plan for very premature babies with lung disease
This trial tests a standardized, team-agreed discharge plan to help preterm babies with lung disease (often called BPD) leave the hospital safely. It may help by making the discharge process more consistent, especially for babies going home on breathing support like oxygen.
Boston, MassachusettsAges birth–1 year - NCT05298748Recruiting
Audio recordings to help breathing control mature in preterm babies
This trial studies whether listening to special “womb” sounds can help a preterm baby’s breathing control develop as they grow. It may help babies who are already breathing on their own (with low or no extra oxygen support).
Cleveland, OhioAges 1 week–1 month - NCT05336890Recruiting
Using past oxygen data to predict risks after premature birth
This study builds a personalized computer model that uses earlier breathing/oxygen information from preterm infants to predict possible health or development outcomes by preschool age. It may help families and doctors better estimate risks and plan support, using information already collected in a previous study.
Chicago, IllinoisAges 7 months–6.9 years - NCT05340465RecruitingPhase 2
IV iron in preterm babies to reduce blood transfusions
This Phase 2 study tests whether giving a specific IV iron (darbe plus IV iron) can help preterm babies need fewer blood transfusions while still keeping their iron levels in a safe range. It focuses on babies in the NICU who were born early, and it compares transfusion use and iron sufficiency over time.
Seattle, WashingtonAges Up to 3 days - NCT05347238Recruiting
Dopamine or norepinephrine for low blood pressure in very preterm babies
This trial compares two common medicines—dopamine versus norepinephrine—to treat low blood pressure in very preterm babies who have suspected or confirmed late-onset bloodstream infection (sepsis). It may help doctors find which medicine works better and more safely for this specific situation.
Phoenix, ArizonaAges 5 months–7 months - NCT05380401Recruiting
DHA and ARA milk fats for very early preterm babies
This study looks at how adding two specific milk fats (DHA and ARA) through enteral feeding affects metabolism in very early preterm infants. It may help researchers understand what these nutrients do in babies born around 25–30 weeks gestation.
Los Angeles, CaliforniaAges Up to 8 months
Hear when a new Preterm Infant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for preterm infant?
- Yes. Clin2 currently lists 156 recruiting preterm infant studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a preterm infant trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a preterm infant trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.